Comparison of hospital resource utilization parameters in patients with nonvalvular atrial fibrillation anticoagulated with rivaroxaban versus warfarin: a retrospective cohort study

被引：0
|
作者：
Jain, Barkha [1 ]
Brunetti, Luigi [2 ]
机构：
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharm Practice & Adm, Piscataway, NJ USA
[2] Robert Wood Johnson Univ Hosp Somerset, Dept Pharm, Somerville, NJ USA
来源：
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
273
引用
收藏
页码：E201 / E201
页数：1
相关论文
共 50 条
  • [21] Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Baker, William L.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Meinecke, Anna-Katharina
    Eriksson, Daniel
    Coleman, Craig, I
    [J]. PHARMACOTHERAPY, 2019, 39 (02): : 196 - 203
  • [22] Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study
    Wetmore, James B.
    Weinhandl, Eric D.
    Yan, Heng
    Reyes, Jorge L.
    Herzog, Charles A.
    Roetker, Nicholas S.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (05) : 569 - +
  • [23] Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure
    Coleman, C. I.
    Baker, W. L.
    Bunz, T. J.
    Eriksson, D.
    Meinecke, A. K.
    Sood, N. A.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1012 - 1012
  • [24] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [25] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [26] Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Peripheral Artery Disease
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. STROKE, 2018, 49
  • [27] Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    [J]. CIRCULATION, 2016, 133 (04) : 352 - 360
  • [28] Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
    Mark J. Alberts
    Jinghua He
    Akshay Kharat
    Veronica Ashton
    [J]. American Journal of Cardiovascular Drugs, 2022, 22 : 425 - 436
  • [29] Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
    Alberts, Mark J.
    He, Jinghua
    Kharat, Akshay
    Ashton, Veronica
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (04) : 425 - 436
  • [30] Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes
    Weir, Matthew R.
    Chen, Yen-Wen
    He, Jinghua
    Bookhart, Brahim
    Campbell, Alicia
    Ashton, Veronica
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (11)
12345